Metronomic capecitabine as adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trialYu‐Pei Chen, Jun Ma, Mei Shi et al.|The Lancet|2021Cited by 234
TGF-β1 secreted by M2 phenotype macrophages enhances the stemness and migration of glioma�cells via the SMAD2/3 signalling pathwayZhengzheng Liu, Yingying Zhang|International Journal of Molecular Medicine|2018Cited by 123
Circadian clock genes promote glioma progression by affecting tumour immune infiltration and tumour cell proliferationZeyu Wang, Quan Cheng, Guan-Hua Su et al.|Cell Proliferation|2021Cited by 78